• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Genet Evol. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

tetano

Editor, Senior Moderator
Infect Genet Evol. 2020 May 5:104351. doi: 10.1016/j.meegid.2020.104351. [Epub ahead of print]
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.


van Dorp L[SUP]1[/SUP], Acman M[SUP]1[/SUP], Richard D[SUP]2[/SUP], Shaw LP[SUP]3[/SUP], Ford CE[SUP]1[/SUP], Ormond L[SUP]1[/SUP], Owen CJ[SUP]1[/SUP], Pang J[SUP]4[/SUP], Tan CCS[SUP]1[/SUP], Boshier FAT[SUP]5[/SUP], Ortiz AT[SUP]6[/SUP], Balloux F[SUP]7[/SUP].

Author information




Abstract

SARS-CoV-2 is a SARS-like coronavirus of likely zoonotic origin first identified in December 2019 in Wuhan, the capital of China's Hubei province. The virus has since spread globally, resulting in the currently ongoing COVID-19 pandemic. The first whole genome sequence was published on January 52,020, and thousands of genomes have been sequenced since this date. This resource allows unprecedented insights into the past demography of SARS-CoV-2 but also monitoring of how the virus is adapting to its novel human host, providing information to direct drug and vaccine design. We curated a dataset of 7666 public genome assemblies and analysed the emergence of genomic diversity over time. Our results are in line with previous estimates and point to all sequences sharing a common ancestor towards the end of 2019, supporting this as the period when SARS-CoV-2 jumped into its human host. Due to extensive transmission, the genetic diversity of the virus in several countries recapitulates a large fraction of its worldwide genetic diversity. We identify regions of the SARS-CoV-2 genome that have remained largely invariant to date, and others that have already accumulated diversity. By focusing on mutations which have emerged independently multiple times (homoplasies), we identify 198 filtered recurrent mutations in the SARS-CoV-2 genome. Nearly 80% of the recurrent mutations produced non-synonymous changes at the protein level, suggesting possible ongoing adaptation of SARS-CoV-2. Three sites in Orf1ab in the regions encoding Nsp6, Nsp11, Nsp13, and one in the Spike protein are characterised by a particularly large number of recurrent mutations (>15 events) which may signpost convergent evolution and are of particular interest in the context of adaptation of SARS-CoV-2 to the human host. We additionally provide an interactive user-friendly web-application to query the alignment of the 7666 SARS-CoV-2 genomes.
Copyright ? 2019. Published by Elsevier B.V.



KEYWORDS:

Betacoronaviridae; Homoplasies; Mutation; Phylogenetics


PMID:32387564DOI:10.1016/j.meegid.2020.104351
 
Back
Top Bottom